InvestorsHub Logo
Followers 0
Posts 25
Boards Moderated 0
Alias Born 04/19/2021

Re: None

Monday, 05/03/2021 8:22:53 PM

Monday, May 03, 2021 8:22:53 PM

Post# of 3647
Zhittya Genesis Medicine announces it has won all lawsuits against CardioVascular BioTherapeutics (CVBT-VT) and the court has ruled that Zhittya owns 100% of its own IP relating to FGF-1. Zhittya is proceeding on using FGF-1 for Therapeutic Angiogenesis for 10 separate medical indications.

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.